TY - JOUR
T1 - Regulation of immune responses in SJL and F1 hybrid mice by γ-irradiated syngeneic lymphoma cell
AU - Katz, Irene R.
AU - Nagase, Fumihiko
AU - Bell, Melvin K.
AU - Ponzio, Nicholas M.
AU - Jeanette Thorbecke, G.
N1 - Funding Information:
I Received February 25,1983; accepted August 12,1983. 2Supported by Public Health Service (PHS) grant CA-14462 from the National Cancer Institute (NCI); by the American Cancer Society, New Jersey Division; by the University of Medicine and Dentistry of New Jersey Foundation grant 28-82; and by the George A. Ohl, Jr., Cancer Research Fund. 3 Animals were maintained under the guidelines set forth by the New York University School of Medicine. 4Department of Pathology, New York University Medical Center, School of Medicine, 550 First Ave., New York, N.Y. 10016. 5Present address: Sloan-Kettering Institute for Cancer Research, 1275 York Ave., New York, N.Y. 10021. 6Supported by the Ministry of Education, Science and Culture of Japan and by a fellowship from the Cancer Research Institute, New York, N.Y. 'University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, N.J. 8 Recipient of PHS Research Career Development Award CA-00833 from the NCI. 9 The help of Ms. Judith Stein in breeding mice is much appreciated.
PY - 1984/1
Y1 - 1984/1
N2 - Syngeneic mixed lymphocyte-stimulating la+ lymphomas of SJL mice [reticulum cell sarcoma(s) (RCS)] were found to modulate immune responses in vivo. Simultaneous injection of 2×107 γ-irradiated or glutaraldehyde-fixed RCS cells with the antigen sheep red blood cells (SRBC) or 2,4,6-trinitrophenol (TNP)-Ficoll markedly suppressed the subsequent plaque-forming cell response in the spleen. The suppression of the anti-SRBC response was prevented by pretreatment of the mice with cyclophosphamide, whereas the suppression of the anti-TNP-Ficoll response was not affected. RCS injection induced high interferon serum titers within 24 hours after injection, which were not prevented by pretreatment with cyclophosphamide. Injection of γ-irradiated RCS cells (γ-RCS) or RCS cell extract 2 days prior to antigen enhanced the anti-SRBC but markedly suppressed the anti-TNP-Ficoll response. Injection of RCS both on day -2 and day 0 enchanced the anti-SRBC response. SJL mice 8–9 months of age showed much less or no suppression when γ-RCS cells were injected on day 0. Certain F1 hybrids of SJL also showed the γ-RCS-induced suppression of the anti-SRBC response. Suppression was seen in SJL x BALB.B but not in SJL x BALB/c mice and in SJL x A.TH but not in SJL x A.TL mice, suggesting an/-region effect. F1, hybrids of SJL by B10 background mice showed no significant suppression. Enhancement of the anti-SRBC response by prior injection of γ-RCS was seen in all F1 hybrid mice examined.
AB - Syngeneic mixed lymphocyte-stimulating la+ lymphomas of SJL mice [reticulum cell sarcoma(s) (RCS)] were found to modulate immune responses in vivo. Simultaneous injection of 2×107 γ-irradiated or glutaraldehyde-fixed RCS cells with the antigen sheep red blood cells (SRBC) or 2,4,6-trinitrophenol (TNP)-Ficoll markedly suppressed the subsequent plaque-forming cell response in the spleen. The suppression of the anti-SRBC response was prevented by pretreatment of the mice with cyclophosphamide, whereas the suppression of the anti-TNP-Ficoll response was not affected. RCS injection induced high interferon serum titers within 24 hours after injection, which were not prevented by pretreatment with cyclophosphamide. Injection of γ-irradiated RCS cells (γ-RCS) or RCS cell extract 2 days prior to antigen enhanced the anti-SRBC but markedly suppressed the anti-TNP-Ficoll response. Injection of RCS both on day -2 and day 0 enchanced the anti-SRBC response. SJL mice 8–9 months of age showed much less or no suppression when γ-RCS cells were injected on day 0. Certain F1 hybrids of SJL also showed the γ-RCS-induced suppression of the anti-SRBC response. Suppression was seen in SJL x BALB.B but not in SJL x BALB/c mice and in SJL x A.TH but not in SJL x A.TL mice, suggesting an/-region effect. F1, hybrids of SJL by B10 background mice showed no significant suppression. Enhancement of the anti-SRBC response by prior injection of γ-RCS was seen in all F1 hybrid mice examined.
UR - http://www.scopus.com/inward/record.url?scp=0021324903&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021324903&partnerID=8YFLogxK
U2 - 10.1093/jnci/72.1.125
DO - 10.1093/jnci/72.1.125
M3 - Article
C2 - 6198549
AN - SCOPUS:0021324903
SN - 0027-8874
VL - 72
SP - 125
EP - 132
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 1
ER -